Streamlining Clinical Development

How a joined-up development strategy pays off for early-stage biotechs

Parexel Biotech’s Nate Akers, VP, Business Development, and Vicky Hsu, Head of Operations in Asia discuss the importance of aligning clinical execution with a clearly defined regulatory strategy.

Read More
Navigating COVID-19 to Support Next-Gen Patient-Focused Treatments

Read More
Loading, please wait

Error - something went wrong!

Let's start a conversation...

Thank you! We'll be in touch soon.
Four Keys to a Smoother Clinical Development Journey

Whitepaper recently published in Fierce Biotech providing perspectives on how the right partner can help bring all the disciplines together for a successful development program.

Read More
Entering a new age of evidence generation: synthetic control models

Expert perspectives from Parexel's Leanne Larson, Senior Vice President and WW Head of Real-World Evidence

Read More
Real-world evidence for more efficent, patient-focused trials

Parexel's Amy McKee and Leanne Larson make a case for an evidence-driven approach to drug development.

Read More
Top Ten Rules for Success in DCTs

Patients’ needs and insights are central to how we design and conduct trials. Here are our top ten rules for a successful DCT...

Read More
How RWE can help Biotechs optimize the value of their asset

Matthew Gordon, VP of Real-World Evidence Strategy, Parexel, and Jimmy Brown, VP, Parexel Biotech discuss how RWE is a tremendously versatile tool for biotech companies at all stages.

Read More
Parexel Biotech Brochure

Learn about the services and approaches that Parexel Biotech offers to help you make an exponential difference in patients’ lives.

Read More
COVID19 The Great Decentralized Clinical Trials Accelerator

Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.

Read More
Rare disease clinical trial patient identification and recruitment

Read More
Genomics & biomarkers: Answers in the blood

Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia.

Watch Video
Getting real-world data into clinical research

Learn more about how to address operational challenges that come with harnessing RWD.

Read More
Top 10 Myths About Working with the FDA for an Oncology Drug Approval

Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.

Learn More
Endpoints That Matter

Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey Ankylosing spondylitis (AS).

Watch Video
The future is now: Decentralized clinical trials during the pandemic and beyond

Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.

Learn More
On-demand webinar: Value of real-world evidence and synthetic control arms

Learn about the benefits that real-world evidence (RWE) can bring to small & mid-size biotech companies.

Watch Webinar
Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.

Read More
COVID-19 and the impact on pediatric clinical trials

The COVID-19 global pandemic has had a significant impact on the conduct of pediatric and adult clinical drug trials. Many trials have halted enrollment, and there are multiple challenges with...

Learn More
COVID-19 and the effect on cellular therapy trials

In clinical trials for cellular and gene therapies, the COVID-19 pandemic has created enormous complexities. Parexel experts Matthew M. Cooney, MD and Roberta L. Steere offer a brief overview.

Learn More
Expediting Biotech Product Development During the COVID-19 Pandemic using Modular Validation Approaches

For over three months the world has been battling COVID-19. COVID-19 is unforgiving and has the ability to overwhelm even the strongest health system or regulatory regime. Even though the...

Learn More
Loading More...